Study | Reason |
---|---|
Active comparator trials | |
Cho et al87 | Single dose |
DRCRN 2010 (Googe et al)88 | <6 months f/u |
Faghihi et al89 | Single dose |
Figueroa et al90 | Single dose |
Isaac et al91 | Single dose |
Paccola et al92 | Single dose |
Prager et al93 | <25 pts per arm |
Ozturk et al94 | Non-RCT |
Marey and Ellakwa95 | <6 months |
Shahin and El-Lakkany96 | Single dose |
Pegaptanib | |
Loftus et al97 | Quality of life data |
Ranibizumab | |
Ferrone and Jonisch98 | <25 pts per arm |
Bevacizumab | |
Solaiman et al99 | Single dose |
DRCRN—Scott et al100 | <25 pts per arm |
Lee101 | Non-RCT |
Isaac et al91 | Single dose |
Trimacinolone | |
Audren et al102 | Single dose (dosing study) |
Audren et al103 | Single dose |
Avitabile104 | Mixed RVO and DMO |
Bandello et al105 | Case report+PDR |
Bonini et al106 | Single dose injection technique |
Cellini et al107 | Single injection PSTI |
Cardillo et al108 | Single injection PSTI |
Chung et al109 | Single injection PSTI |
Dehghan et al110 | Single dose |
DRCRN—Chew et al 111 | <25 pts per arm |
Gil et al112 | <25 pts per arm |
Entezari et al113 | <6 months |
Hauser et al114 | Single dose |
Jonas et al115 | Single dose |
Joussen et al116 | Study protocol |
Avci and Kaderli117 | Anaesthetic technique |
Kang et al118 | Single dose |
Kim et al119 | Single injection and CME |
Lam et al120 | Single injection |
Lee121 | Single injection |
Maia et al122 | Single dose |
Massin et al123 | Single dose |
Mohamed et al124 | Post hoc analysis |
Nakamura et al125 | Single dose |
Spandau et al126 | Single dose |
Tunc127 | <6 months |
Verma et al128 | Single dose |
Wickremasinghe et al129 | Single dose |
Yalcinbayir et al130 | Single dose |
Dexamethasone | |
Haller et al131 | <6 months |
Haller et al132 | <25 pts per arm |
Kuppermann et al 133 | Mixture of macular oedema causes |
Boyer et al134 | Non-randomised |
Fluocinolone | |
Campochiaro et al135 | <25 pts per arm |
Diclofenac | |
Elbendary71 | <35 pts per arm |
CME, cystoid macular edema; DMO, diabetic macular oedema PDR, proliferative diabetic retinopathy; PSTI, posterior subtenon injection; RVO, retinal vein occlusion.